Category Archives:
BMW starts producing new electric model, commits to emissions-free transport at main plant
By Victoria Waldersee BERLIN (Reuters) - German automaker BMW's first sales-ready battery electric i4 models rolled off production lines at its main plant in Munich on Friday, as the company expands i...
Oct 22, 2021
Top House Democrat sees U.S. spending deal framework by end of weekend
WASHINGTON (Reuters) -Lawmakers hope to reach a framework agreement this weekend on a huge spending plan that contains many of President Joe Biden's social programs, U.S. House of Representatives Majo...
Oct 22, 2021
Beyond Meat cuts revenue forecast as retail demand drops
By Uday Sampath Kumar (Reuters) - Beyond Meat Inc on Friday cut its third-quarter revenue forecast, blaming a drop in demand from grocery stores and lingering effects of the Delta variant of the coron...
Oct 22, 2021
Spain’s airlines see more winter flights than pre-COVID, but fuel prices bite
By Clara-Laeila Laudette MADRID (Reuters) - Spain plans more flights this winter than before the pandemic as an incipient recovery buoys hard-hit airlines, although surging fuel prices are a concern, ...
Oct 22, 2021
K-pop megaband BTS drops Sony for Universal – WSJ
(Reuters) -South Korean megaband BTS has replaced Sony Music's Columbia Records with Universal Music Group as its distribution and marketing partner, the Wall Street Journal reported on Friday, citing...
Oct 22, 2021
Indian beauty startup Nykaa aims IPO at valuation of above $7 billion
MUMBAI (Reuters) - Indian startup FSN E-Commerce Ventures, which runs beauty company Nykaa, has priced its initial public offering (IPO) at 1,085 rupees to 1,125 rupees per share, giving it a valuatio...
Oct 22, 2021
India’s Paytm gets regulator approval for IPO -source
NEW DELHI (Reuters) - Ant Group-backed Indian fintech firm Paytm has received approval from the country's capital market regulator's for its $2.2 billion initial public offering (IPO), a source direct...
Oct 22, 2021
Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
NEW YORK (Reuters) – The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of five to 11 year olds, the U.S. drug maker said on Friday. Sixteen c...
Oct 22, 2021
European industry calls for EU/China talks on magnesium shortages
By Eric Onstad LONDON (Reuters) - The European Commission must launch talks with China to restart shipments of magnesium to ease severe shortages and avoid plant shutdowns that could hit millions of j...
Oct 22, 2021
Evergrande averting default to do little to revive China property bond sales
By Scott Murdoch and Karin Strohecker HONG KONG (Reuters) - China property companies could be locked out of offshore debt markets until early next year as global investors wait on the sidelines for em...
Oct 22, 2021
Peoria, IL, USA
50 °F Clear
